Evidence map›Paper›PMID 19889730›Full record

ArticleJournal of leukocyte biology2010

ICOS promotes IL-17 synthesis in colonic intraepithelial lymphocytes in IL-10-/- mice.

Jeremy S Schaefer, Dina Montufar-Solis, Nadarajah Vigneswaran, John R Klein

Abstract read
In one paragraph

Article in Journal of leukocyte biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Loss of n-6 fatty acid induced pediatric obesity protects against acute murine colitis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeremy S SchaeferDepartment of Diagnostic Sciences, Dental Branch, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Dina Montufar-Solis
Nadarajah Vigneswaran
John R Klein
The University of Texas Health Science Center at Houston · US

Funding

UT-H Comprehensive Research Training ProgramT32DE015355 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI STANCEL, GEORGE M. · 2003 to 2007
$3.2M
GUT-DERIVED IMMUNE EFFECTOR CELLSR01DK035566 · NIDDK · UNIVERSITY OF TULSA · PI KLEIN, JOHN R · 1988 to 2012
$2.9M
GUT-DERIVED IMMUNE EFFECTOR CELLSR23DK035566 · NIDDK · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI KLEIN, JOHN R · 1986 to 1987
–
NIDCR NIH HHS DE015355NIDDK NIH HHS DK035566NIDDK NIH HHS R01 DK035566
6 · The paper itself

Abstract

In the absence of IL-10, colonic inflammation ensues, which is characterized by high levels of IL-17. Here, we demonstrate a direct correlation between ICOS expression and IL-17 production in cIELs. IL-10(-/-) mice had increased numbers of cIELs and greater colon weight. Although the CD69 early activation antigen was expressed on cIELs from normal and IL-10(-/-) mice, ICOS was expressed only on cIELs from IL-10(-/-) mice. IL-17-producing cells in IL-10(-/-) mice consisted of CD4(+) and CD8(+) cIELs; however, CD4(+) cells were the predominant IL-17-producing cell population. Culture of cIELs from IL-10(-/-) mice with IL-23 resulted in an increase in ICOS and IL-17 expression, whereas IL-10 suppressed expression of ICOS and IL-17. This occurred in primary cultures and recall stimulation experiments. The ICOS ligand B7RP-1 was up-regulated on colonic epithelial cells and on a population of large granular leukocytes during inflammation. Culture of cIELs with B7RP-1(+) DCs enhanced IL-17A production from normal cIELs but failed to do so using cIELs from ICOS(-/-) mice. In vivo treatment of IL-10(-/-) mice with antibody to ICOS resulted in a significant reduction in colonic pathology. These findings implicate ICOS as an activational signal of Th17 cells during chronic intestinal inflammation, and they suggest that under some conditions, control of ICOS expression may help to suppress chronic intestinal inflammation.

Indexed as

AnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteB7-1 AntigenCD4-Positive T-LymphocytesCD69 AntigensCD8-Positive T-LymphocytesCells, CulturedColonGene Expression RegulationInducible T-Cell Co-Stimulator LigandInducible T-Cell Co-Stimulator ProteinInflammationInterleukin-10Interleukin-17Intestinal MucosaAntigens, CDAntigens, Differentiation, T-LymphocyteB7-1 AntigenCD69 AntigensIcos protein, mouseInducible T-Cell Co-Stimulator LigandInducible T-Cell Co-Stimulator ProteinInterleukin-10Interleukin-17Lectins, C-Type

Identifiers

PMID19889730
PMCPMC2812556
OpenAlexW2156251418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.